Top Markets
Coin of the day
Celadon Pharmaceuticals Plc Celadon Pharmaceuticals Plc

Celadon Pharmaceuticals Plc

CEL
Rank in Stocks #40708
Celadon Pharmaceuticals Plc functions as a drug development company,... Celadon Pharmaceuticals Plc functions as a drug development company, concentrating on the discovery, production, and distribution of cannabinoid compounds for certified medical uses. The firm's primary activity involves the indoor, hydroponic cultivation of THC cannabis, which is then incorporated into medicinal products targeting chronic pain. Furthermore, Celadon intends to broaden its research into cannabinoids, exploring their therapeutic applications not only for persistent pain but also for conditions such as autism and multiple sclerosis. Established in 2018, the company maintains its headquarters in London, United Kingdom.
Share Price
$0.00179028
Last synced: 2025-07-28
Market Cap
$94.61K
Change (1 day)
-0.54%
Change (1 year)
0.00%
Country
GB
Trade Celadon Pharmaceuticals Plc (CEL)

Category

P/B ratio for Celadon Pharmaceuticals Plc (CEL)
P/B ratio as of 2026 TTM: 0
According to Celadon Pharmaceuticals Plc latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Celadon Pharmaceuticals Plc from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors